Advanced Search

    column
    Chinese Expert Consensus on Key Issues in Perioperative Immunotherapy for Resectable Non-Small Cell Lung Cancer
    Expert Consensus Group on Key Issues in Perioperative Immunotherapy
    2026, 26(2): 63-76. DOI: 10.12019/j.issn.1671-5144.202507025
    Abstract PDF
    HARMONi Trial Review: New Advances in Treatment Options After EGFR-TKI Resistance//
    WANG Jin-lin, CHU Qian
    2026, 26(2): 77-80. DOI: 10.12019/j.issn.1671-5144.202601032
    Abstract PDF
    Progress in the Management of Resectable Esophageal Squamous Cell Carcinoma
    LIU Zhi-peng, YU Xin, MA Kai
    2026, 26(2): 81-90. DOI: 10.12019/j.issn.1671-5144.202511050
    Abstract PDF
    2025 Annual Progress in Gastric Cancer and Colorectal Cancer
    YU Dan-dan, ZHANG Tao
    2026, 26(2): 91-96. DOI: 10.12019/j.issn.1671-5144.202601009
    Abstract PDF
    Mechanism of ARID1A Knockout Promoting Invasion and Metastasis of Lung Adenocarcinoma by Regulating the EMT Pathway
    LI Ni-jia, YAN Wen-qing, LU Dan-xia, LI Chen-peng, MA Chi-yu, ZHU Ke-xin, ZHONG Xue-ying, YOU Zi-zhong, QIAO Fei, LI Si-xian, LIANG Jia-le, ZHANG Xu-chao
    2026, 26(2): 97-106. DOI: 10.12019/j.issn.1671-5144.202603026
    Abstract PDF
    Homozygous Deletion of CDKN2A Mediates Non-Small Cell Lung Cancer Immunotherapy Resistance by Aberrantly Regulating the Antigen Presentation Pattern
    HAN Jie-fei, CHEN Kai, LI Wen-bin, LIN Gen
    2026, 26(2): 107-117. DOI: 10.12019/j.issn.1671-5144.202603031
    Abstract PDF
    Transcriptomic Profiling Characteristics of Immune Infiltration and Antioxidant Pathway in STK11mutTP53wtKRASmut Lung Cancers
    ZHANG Xin-yue, YOU Zi-zhong, CHEN Yu, ZHANG Pai, LV Zhi-yi, XIE Zhi
    2026, 26(2): 118-126. DOI: 10.12019/j.issn.1671-5144.202604010
    Abstract PDF